Remdesivir in The Treatment of COVID-19

Am J Nurs. 2021 Jan 1;121(1):55. doi: 10.1097/01.NAJ.0000731668.01845.8c.

Abstract

According to this study: The antiviral remdesivir is superior to placebo in the treatment of patients hospitalized with COVID-19.A variety of therapeutic approaches are needed to continue to improve outcomes in COVID-19 patients.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adenosine Monophosphate / analogs & derivatives*
  • Adenosine Monophosphate / therapeutic use
  • Alanine / analogs & derivatives*
  • Alanine / therapeutic use
  • Antiviral Agents / therapeutic use*
  • COVID-19 Drug Treatment*
  • Double-Blind Method
  • Female
  • Humans
  • Male
  • Middle Aged

Substances

  • Antiviral Agents
  • remdesivir
  • Adenosine Monophosphate
  • Alanine